| adrenal glands |
 |
Glands located on top of each kidney that secrete hormones and are responsible for producing androgen, the precursor of estrogen, in postmenopausal women.
|
| aromatase inhibitor |
| |
A type of hormone therapy that blocks the production of estrogen in peripheral tissue, such as adipose tissue (fat), thereby reducing overall circulating estrogen levels.
|
| axillary lymph nodes |
| |
Lymph nodes below the shoulder joint that are bounded by chest muscles. Many lymphatic vessels of the breast lead to lymph nodes under the arm.
|
| axillary lymph node dissection (ALND) |
| |
Removal of all or some of the lymph nodes in the armpit.
|
| body mass index (BMI) |
| |
A useful tool to determine whether a person is underweight, a healthy weight, overweight, or obese. High BMI (greater thann or equal to 25) may be associated with serious
health problems.
|
| carcinoma |
 |
A cancerous tumor.
|
| chemotherapy |
| |
The use of systemic medications to treat cancer.
|
| estrogen |
| |
A naturally occurring hormone produced by the ovaries of premenopausal women that controls the development and maintenance of female sex characteristics and the reproductive
system. Estrogen may stimulate the growth of certain cancers.
|
| estrogen replacement therapy (ERT) |
| |
ERT is usually given to women to help alleviate symptoms of menopause, but has been linked to an increased risk of breast cancer and endometrial cancer.
|
| FARESTON® (toremifene citrate) |
| |
An effective and well-tolerated selective estrogen receptor modulator (SERM) that binds to estrogen receptors to help prevent cancer cells from growing and dividing.
Proven to extend survival in women in ER-positive or ER-unknown advanced breast cancer.
|
| hormone therapy |
| |
A type of therapy that interferes with the actions of hormones, such as estrogen, that support cancer-cell growth.
|
| in situ carcinoma |
| |
An abnormal growth of cells that has not spread from where it originated. This type of cancer may begin in the milk ducts (ductal) or the milk glands (lobular).
|
| invasive cancer |
| |
Cancer that is localized in the breast or has spread to other parts of the body (metastatic).
|
| lumpectomy |
| |
Breast-conserving surgery in which only cancerous tissue and a small amount of surrounding tissue are surgically removed.
|
| luteinizing hormone-releasing hormone (LH-RH) agonists |
| |
A class of drugs that works by turning off the production of estrogen by the ovaries of premenopausal women.
|
| lymph nodes |
 |
Small, pea-shaped collections of immune system tissue that remove cell waste and fluids from lymph. Lymph is a clear fluid that contains immune system cells and tissue
waste products, and is carried in lymph vessels that lead to the lymph nodes. Lymph nodes help fight infections and also have a role in fighting cancer. Also called lymph
glands.
|
| lymph node surgery |
| |
Surgery to determine if the cancer has spread to the lymph nodes and to other parts of the body. See axillary lymph node dissection
and sentinel lymph node dissection.
|
| mastectomy |
| |
Surgical removal of the entire breast.
|
| metastatic |
| |
A term meaning that the cancer has spread from its place of origination to other parts of the body.
|
| oophorectomy |
| |
Removal of the ovaries.
|
| partial mastectomy |
 |
Breast-conserving surgery in which more of the tissue surrounding the tumor is removed (wide excision) than in a lumpectomy.
|
| quadrantectomy |
| |
Surgical removal of one fourth of the breast.
|
| radiation therapy |
| |
Cancer treatment that uses radioactive energy to destroy or shrink tumor cells.
|
| selective estrogen receptor modulator (SERM) |
| |
A type of hormonal therapy that blocks the growth of tumors by binding to estrogen receptors in the breast cancer cell and preventing estrogen from binding.
|
| sentinel lymph node dissection (SLND) |
| |
A surgical procedure used to determine if cancer has spread to the axillary lymph nodes.
|
| systemic therapy |
| |
Any treatment given orally or intravenously that enters the bloodstream.
|
| tamoxifen |
| |
A SERM that binds to estrogen receptors to help prevent cancer cells from growing and dividing. Proven to extend survival in women with breast cancer.
|

Prescribing Information
Important Safety Information
Online Privacy Policy
Home • About FARESTON® • Living
With Breast Cancer • Support Groups • Contact Us
FARESTON® is a registered trademark in the U.S. of GTx, Inc.
© 2006 GTx, Inc. Memphis, TN 38163
While GTx, Inc. makes reasonable efforts to include accurate, up-to-date information on this site, GTx, Inc. makes no warranties or representations as to its accuracy. GTx, Inc. assumes no liability for any errors or omissions in the content of this site.
|